View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Respondents
- Meril GmbHOperating co.
- Meril Life Sciences Pvt Ltd.Operating co.
- Meril Italy srlOperating co.
Representatives- Andreas von Falck-Hogan Lovells International LLP
- Division
- Munich LD
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Apr 8, 2024
- EPO Opposition
- Abbott Cardiovascular Systems, Inc.Admissible2022-02-04
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge Tobias Pichlmaier | Locked |
| Judge Stefan Wilhelm | Locked |
| Judge Margot Kokke | Locked |
At the UPC: Edwards Lifesciences Group (57 cases)·Meril Group (60 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 13 other proceedings
UPC CFI 1160/2026·UPC CoA 932/2025·UPC CoA 933/2025·UPC CFI 404/2025·UPC CFI 405/2025 and 8 more
1 other defendants litigating the same or a related patent
Decisions
- 2024-04-08
Summary: Order from the Munich Local Division (UPC_CFI_501/2023) rejecting Meril's request for a three-week extension to file its Statement of Defence following a language change from German to English. The Court held that a language change agreed to shortly before the deadline does not constitute exceptional circumstances justifying an extension, consistent with the UPC's principle that extensions should be granted only in exceptional cases.
Show the legal issues (3)
- Extension of deadline (R. 9.3 RoP)
- Language change as grounds for extension
- Exceptional circumstances
Documents
- 9D6DAF9A7888F062685525CF5C76C188_en.pdf2024-04-08EN